Package 62011-0396-1

Brand: naproxen sodium pm

Generic: naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 62011-0396-1
Digits Only 6201103961
Product NDC 62011-0396
Description

1 BOTTLE, PLASTIC in 1 BOX (62011-0396-1) / 20 TABLET in 1 BOTTLE, PLASTIC

Marketing

Marketing Status
Discontinued 2027-01-31
Brand naproxen sodium pm
Generic naproxen sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d3f5df98-41db-4d8f-b8e7-10959d821a04", "openfda": {"upc": ["0052569142516"], "unii": ["TC2D6JAD40", "9TN87S3A3C"], "rxcui": ["1550957"], "spl_set_id": ["7aadfdd4-f8f5-4b7a-a388-1889c3d7d8ba"], "manufacturer_name": ["Strategic Sourcing Services LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (62011-0396-1)  / 20 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "62011-0396-1", "marketing_end_date": "20270131", "marketing_start_date": "20190131"}], "brand_name": "Naproxen Sodium PM", "product_id": "62011-0396_d3f5df98-41db-4d8f-b8e7-10959d821a04", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "62011-0396", "generic_name": "Naproxen Sodium", "labeler_name": "Strategic Sourcing Services LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naproxen Sodium PM", "active_ingredients": [{"name": "DIPHENHYDRAMINE HYDROCHLORIDE", "strength": "25 mg/1"}, {"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA209726", "marketing_category": "ANDA", "marketing_end_date": "20270131", "marketing_start_date": "20190131"}